Related Experiment Videos
[Cyclosporin induced gingival hyperplasia].
M Gonzalez-Jaranay Ruiz1, F Mesa Aguado
1Universidad de Granada.
Revista Europea De Odonto-Estomatologia
|July 1, 1991
Summary
Cyclosporine, an immunosuppressant, can cause gingival overgrowth in transplant patients. This study found no clear link between cyclosporine dosage, age, and the severity of this common side effect.
Area of Science:
- Immunopharmacology
- Periodontology
Context:
- Cyclosporine is a vital immunosuppressive medication for transplant recipients.
- Gingival overgrowth is a known adverse effect of cyclosporine therapy.
- This condition necessitates specific periodontal interventions.
Purpose:
- To investigate the relationship between cyclosporine dosage, patient age, and the incidence of gingival overgrowth in transplant patients.
Summary:
- Five transplant patients (one liver, four kidney) on long-term cyclosporine therapy were studied.
- One patient showed no gingival overgrowth, while the others required periodontal treatment for hyperplasia.
- No clear correlation was found between drug dosage, patient age, and the observed tissue effects.
Impact:
- Highlights the unpredictable nature of cyclosporine-induced gingival overgrowth.
- Suggests that factors beyond dosage and age may influence this adverse drug reaction.
- Informs clinical monitoring and management strategies for transplant patients on cyclosporine.